Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M118,808Revenue $M20,063Net Margin (%)27.7Altman Z-Score2.8
Enterprise Value $M122,031EPS $6.7Operating Margin %33.3Piotroski F-Score5
P/E(ttm)20.7Beneish M-Score-2.7Pre-tax Margin (%)30.4Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %11.2Quick Ratio5.1Cash flow > EarningsY
Price/Sales5.95-y EBITDA Growth Rate %10.4Current Ratio5.5Lower Leverage y-yY
Price/Free Cash Flow15.3y-y EBITDA Growth Rate %21.8ROA % (ttm)8.3Higher Current Ratio y-yY
Dividend Yield %1.8PEG2.1ROE % (ttm)22.9Less Shares Outstanding y-yN
Payout Ratio %35.0Shares Outstanding M760ROIC % (ttm)20.1Gross Margin Increase y-yN

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMGNJoel Greenblatt 2015-03-31 Add0.37%$150.01 - $170.1
($157.49)
$ 156.26-1%Add 2874.44%309,134
AMGNFirst Eagle Investment 2015-03-31 Reduce-0.06%$150.01 - $170.1
($157.49)
$ 156.26-1%Reduce 23.66%497,622
AMGNDodge & Cox 2015-03-31 Reduce$150.01 - $170.1
($157.49)
$ 156.26-1%Reduce 17.65%54,704
AMGNMario Gabelli 2015-03-31 Add$150.01 - $170.1
($157.49)
$ 156.26-1%Add 1.23%39,985
AMGNKen Fisher 2015-03-31 Add$150.01 - $170.1
($157.49)
$ 156.26-1%Add 1.41%156,623
AMGNVanguard Health Care Fund 2014-12-31 Reduce-0.51%$130.45 - $171.64
($155.84)
$ 156.260%Reduce 20.54%5,580,485
AMGNMario Gabelli 2014-12-31 Reduce-0.02%$130.45 - $171.64
($155.84)
$ 156.260%Reduce 34.11%39,500
AMGNJoel Greenblatt 2014-12-31 Add0.01%$130.45 - $171.64
($156.25)
$ 156.260%Add 285.93%10,393
AMGNVanguard Health Care Fund 2014-09-30 Reduce-0.32%$115.39 - $144.01
($130.57)
$ 156.2620%Reduce 12.75%7,022,755
AMGNFirst Eagle Investment 2014-09-30 Buy 0.25%$115.39 - $144.01
($130.57)
$ 156.2620%New holding714,178
AMGNKen Fisher 2014-09-30 Add0.02%$115.39 - $144.01
($130.57)
$ 156.2620%Add 83.59%156,629
AMGNJoel Greenblatt 2014-09-30 Reduce-0.01%$115.39 - $144.01
($130.57)
$ 156.2620%Reduce 72.90%2,693
AMGNRuane Cunniff 2014-09-30 Buy $115.39 - $144.01
($130.57)
$ 156.2620%New holding1,617
AMGNVanguard Health Care Fund 2014-06-30 Reduce-0.06%$110.29 - $126.07
($115.88)
$ 156.2635%Reduce 2.00%8,049,455
AMGNMario Gabelli 2014-06-30 Add0.02%$110.29 - $126.07
($115.72)
$ 156.2635%Add 85.28%60,335
AMGNJoel Greenblatt 2014-06-30 Buy 0.02%$110.29 - $126.07
($115.72)
$ 156.2635%New holding9,938
AMGNKen Fisher 2014-06-30 Add0.01%$110.29 - $126.07
($115.72)
$ 156.2635%Add 71.02%85,316
AMGNDodge & Cox 2014-06-30 Reduce$110.29 - $126.07
($115.88)
$ 156.2635%Reduce 18.82%85,857
AMGNVanguard Health Care Fund 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 156.2629%Reduce 6.40%8,213,855
AMGNJoel Greenblatt 2014-03-31 Sold Out -0.06%$113.48 - $127.47
($121.04)
$ 156.2629%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Balachandran MadhavanEVP, Operations 2015-05-07Sell21,750$157.87-1.02view
Tross Stuart ASVP, Human Resources 2015-04-23Sell3,012$169.31-7.71view
Harper Sean EEVP, Research & Development 2015-04-22Sell28,000$171.58-8.93view
Tross Stuart ASVP, Human Resources 2015-03-03Sell4,415$157.74-0.94view
BALTIMORE DAVIDDirector 2015-03-02Sell3,647$158.76-1.57view
Bradway Robert AChairman, CEO and President 2015-02-11Sell22,000$152.692.34view
HERRINGER FRANK CDirector 2015-02-05Buy3,000$152.292.61view
de Carbonnel FrancoisDirector 2014-12-03Sell3,000$168.01-6.99view
Harper Sean EEVP, Research & Development 2014-08-05Sell14,000$127.2922.76view
Patton Cynthia MSVP & CCO 2014-08-05Sell2,644$127.9722.11view

Press Releases about AMGN :

    Quarterly/Annual Reports about AMGN:

    News about AMGN:

    Articles On GuruFocus.com
    PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015 
    Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
    Amgen’s Cholesterol Fighting Drug Receives EU Approval May 26 2015 
    Crouching Tigers, Hidden Assets – Smead Capital Management Apr 30 2015 
    securities Apr 27 2015 
    Amgen Reports An Upbeat Q1 Earnings Apr 23 2015 
    Amgen Inc.’s First Quarter Earnings Preview – What Could Be In Store? Apr 20 2015 
    Amgen’s First Drug For Cardiovascular Disease Gets The Green Light Apr 17 2015 
    Vanguard Health Care Fund Comments on Amgen Inc Mar 27 2015 
    Vanguard Health Care Fund 2014 Annual Report Mar 27 2015 

    More From Other Websites
    Amgen Takes a Hit, Shelves Potential Blockbuster May 29 2015
    Build a Billionaire Portfolio With These 20 Stocks May 29 2015
    Amgen, Merck Expand Collaboration May 29 2015
    Amgen And Merck Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec... May 29 2015
    Amgen And Merck Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec... May 29 2015
    Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In... May 29 2015
    6:46 am Amgen presents pooled Phase 3 AMG 416 data for the treatment of secondary... May 29 2015
    Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In... May 29 2015
    Amgen Launches Program To Further Advance Basic Biology Research May 28 2015
    Amgen Launches Program To Further Advance Basic Biology Research May 28 2015
    Big Pharma and Insurers Play Nice May 28 2015
    ASCO Immunotherapy Preview: These Cancer-Killing Viruses May Save Lives May 28 2015
    PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015
    Amgen To Present At The Jefferies 2015 Global Healthcare Conference May 27 2015
    Amgen To Advance Understanding Of The Treatment Of Blood Cancers At 20th Congress of European... May 27 2015
    Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European... May 27 2015
    Amgen To Present At The Jefferies 2015 Global Healthcare Conference May 27 2015
    Amgen To Advance Understanding Of The Treatment Of Blood Cancers At 20th Congress of European... May 27 2015
    Here Is How AstraZeneca and Amgen Will Be Hit By The Cancelled Collaboration May 27 2015
    Amgen, AstraZeneca End Development Pact; Shares Sink May 26 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK